Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Oragenics Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 29 | 33 | +4 |
| Shares | 10.7M | 11.1M | +378.0K (+3.5%) |
| Value | $6.82M | $4.96M | −$1.86M (−27.3%) |
New holders (6)
Institutions that held Oragenics Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 70,402 | $31.0K | 0.00% |
| Two Sigma Securities, LLC | 68,503 | $31.0K | 0.01% |
| Strategies Wealth Advisors, LLC | 10,001 | $4.46K | 0.00% |
| Bank of America Corp | 115 | $0 | 0.00% |
| Morgan Stanley | 3 | $0 | 0.00% |
| Cornerstone Advisory, LLC | 25 | $0 | 0.00% |
Sold out (2)
Institutions that held Oragenics Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| HRT Financial LP | 17,250 | $10.0K |
| Gerber Kawasaki Wealth & Investment Management | 1 | – |